Home Drug Codes J Codes J2993 · RETAVASE
Updated July 1st, 2026

RETAVASE J Code: J2993

Injection, reteplase, 18.1 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, reteplase, 18.1 mg
HCPCS Added Date January 1, 2001
Manufacturer Chiesi
Route of Administration Intravenous
Generic Status Single-Source; Branded

About RETAVASE

Retavase is a medication aligned to the HCPCS J Code: J2993 for billing, pricing, and reimbursement purposes in the United States. Classified under Cardiology, it is administered via the intravenous route and manufactured by Chiesi.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to J2993. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

RETAVASE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Retavase (J2993) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

RETAVASE Medically Unlikely Edits (MUE)

The most billing units of J2993 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 18.1 mg.

Practitioner Office & Hospital Outpatient
2 units / day
= 36.2 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

RETAVASE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acute ST-elevation myocardial infarction (STEMI)

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Retavase billing and coding guide?
We have not yet identified a manufacturer source of Retavase billing and coding information.
Are there any available Retavase patient assistance programs?
Our team did not identify a source for Retavase patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Retavase prescribing information?
RETAVASE prescribing information can be found at the link below: Visit Here →
Where can I find Retavase side effect information?
Our team has not yet identified a source of side effects information for RETAVASE. Please check back in a few weeks.
Does billing RETAVASE require JZ/JW wastage modifiers?
CMS has identified RETAVASE(J2993) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.